The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(5-(2-(3-hydroxypiperidin-1-yl)oxazol-5-yl)-4-methylthiazol-2-yl)acetamide ID: ALA2204794
Chembl Id: CHEMBL2204794
PubChem CID: 71452284
Max Phase: Preclinical
Molecular Formula: C14H18N4O3S
Molecular Weight: 322.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)Nc1nc(C)c(-c2cnc(N3CCCC(O)C3)o2)s1
Standard InChI: InChI=1S/C14H18N4O3S/c1-8-12(22-13(16-8)17-9(2)19)11-6-15-14(21-11)18-5-3-4-10(20)7-18/h6,10,20H,3-5,7H2,1-2H3,(H,16,17,19)
Standard InChI Key: HDVSIMMLUNLLCM-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 322.39Molecular Weight (Monoisotopic): 322.1100AlogP: 2.03#Rotatable Bonds: 3Polar Surface Area: 91.49Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.96CX Basic pKa: 0.25CX LogP: 0.76CX LogD: 0.66Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.90Np Likeness Score: -1.33
References 1. Oka Y, Yabuuchi T, Fujii Y, Ohtake H, Wakahara S, Matsumoto K, Endo M, Tamura Y, Sekiguchi Y.. (2012) Discovery and optimization of a series of 2-aminothiazole-oxazoles as potent phosphoinositide 3-kinase γ inhibitors., 22 (24): [PMID:23122859 ] [10.1016/j.bmcl.2012.10.028 ]